Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Napco Security Technologies
NSSC
$1.37B
| $3.76M | ﹤0.01% |
136,737
+8,577
| +7% | +$231K |
|
2502
FlexShares Quality Dividend Defensive Index Fund
QDEF
$562M
| $3.76M | ﹤0.01% |
73,009
+46,806
| +179% | +$2.37M |
|
2503
Hyster-Yale Materials Handling
HY
$618M
| $3.75M | ﹤0.01% |
148,066
+74,613
| +102% | +$2.08M |
|
2504
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $3.74M | ﹤0.01% |
122,043
+495
| +0.4% | +$14.5K |
|
2505
Inogen
INGN
$153M
| $3.74M | ﹤0.01% |
189,820
-16,267
| -8% | -$350K |
|
2506
Vanda Pharmaceuticals
VNDA
$316M
| $3.74M | ﹤0.01% |
505,593
-258,012
| -34% | -$2.51M |
|
|
DCT
2507
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $3.73M | ﹤0.01% |
309,670
-18,162
| -6% | -$208K |
|
2508
Orthofix Medical
OFIX
$421M
| $3.73M | ﹤0.01% |
181,758
-9,669
| -5% | -$171K |
|
2509
Orion
OEC
$364M
| $3.72M | ﹤0.01% |
208,618
-35,227
| -14% | -$592K |
|
2510
Seneca Foods Class A
SENEA
$1.3B
| $3.71M | ﹤0.01% |
60,882
-7,758
| -11% | -$477K |
|
2511
Rocket Pharmaceuticals
RCKT
$381M
| $3.71M | ﹤0.01% |
189,468
+38,737
| +26% | +$713K |
|
|
ZYXI
2512
DELISTED
Zynex
ZYXI
| $3.7M | ﹤0.01% |
265,791
-8,907
| -3% | -$108K |
|
2513
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.4B
| $3.69M | ﹤0.01% |
77,901
-13,562
| -15% | -$641K |
|
2514
Nektar Therapeutics
NKTR
$2.47B
| $3.69M | ﹤0.01% |
108,760
-5,872
| -5% | -$284K |
|
|
RFP
2515
DELISTED
Resolute Forest Products Inc.
RFP
| $3.66M | ﹤0.01% |
169,713
+9,935
| +6% | +$208K |
|
2516
Fate Therapeutics
FATE
$300M
| $3.66M | ﹤0.01% |
363,074
-27,195
| -7% | -$511K |
|
2517
West Bancorporation
WTBA
$508M
| $3.66M | ﹤0.01% |
143,129
+12,377
| +9% | +$285K |
|
2518
Vodafone
VOD
$37.9B
| $3.65M | ﹤0.01% |
360,999
-2,842,471
| -89% | -$31.9M |
|
2519
Great Southern Bancorp
GSBC
$889M
| $3.65M | ﹤0.01% |
61,362
-8,376
| -12% | -$508K |
|
2520
Aclaris Therapeutics
ACRS
$851M
| $3.65M | ﹤0.01% |
231,613
-2,269
| -1% | -$36.5K |
|
2521
iShares Agency Bond ETF
AGZ
$565M
| $3.64M | ﹤0.01% |
34,232
+4,262
| +14% | +$454K |
|
2522
Vale
VALE
$58B
| $3.64M | ﹤0.01% |
214,518
-8,965
| -4% | -$135K |
|
2523
UFP Technologies
UFPT
$2.49B
| $3.63M | ﹤0.01% |
30,816
-3,380
| -10% | -$360K |
|
2524
Republic Bancorp
RBCAA
$1.92B
| $3.62M | ﹤0.01% |
88,534
+9,810
| +12% | +$419K |
|
|
VTYX
2525
DELISTED
Ventyx Biosciences
VTYX
| $3.62M | ﹤0.01% |
110,387
+29,942
| +37% | +$887K |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.